Detalhe da pesquisa
1.
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Nature
; 620(7973): 409-416, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532934
2.
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.
Gynecol Oncol
; 173: 98-105, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105063
3.
Determinants of the access to remote specialised services provided by national sarcoma reference centres.
BMC Cancer
; 21(1): 631, 2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049529
4.
BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres.
Br J Haematol
; 192(3): e94-e98, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421031
5.
Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer.
Nutr Cancer
; 66(4): 583-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24707897
6.
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.
Gastric Cancer
; 17(2): 341-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23739764
7.
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
Eur J Cancer
; 201: 113589, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382153
8.
Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
Eur J Cancer
; 204: 114048, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653033
9.
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.
Gastroenterology
; 143(3): 664-674.e6, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22705007
10.
The influenza A (H1N1) pandemic in Reunion Island: knowledge, perceived risk and precautionary behaviour.
BMC Infect Dis
; 13: 34, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23347821
11.
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVOREN.
Clin Genitourin Cancer
; 21(6): 643-652, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635052
12.
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.
Mol Oncol
; 17(1): 27-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370117
13.
Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial.
Eur Urol Oncol
; 2023 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813745
14.
Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study.
Eur J Cancer
; 182: 66-76, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746010
15.
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Science
; 380(6649): eabo2296, 2023 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289890
16.
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial.
JAMA Oncol
; 8(7): 1001-1009, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551299
17.
Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
Clin Genitourin Cancer
; 20(5): 488-494, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977881
18.
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640928
19.
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?
Cancers (Basel)
; 14(11)2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681600
20.
Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study.
Oncology
; 81(5-6): 395-402, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22269999